Time To Efficacy and Onset Of Action Of Linezolid

Phase 4CompletedNCT00147511

Pfizer118 enrolled

Overview

To assess the onset of action of linezolid

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

118

Conditions

Gram-Positive Bacterial Infections Skin and Connective Tissue Diseases

Interventions

linezolidDRUG

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * suspected grampositive infection * fever \> 38 C Exclusion Criteria: * Infections to be treated successfully by surgical procedures

Outcomes

Primary Outcomes

Time to defervescence

Secondary Outcomes

Reduction of CRP levels Reduction of leucocyte count

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.